Total Payments
$63,460
2024 Payments
$837.54
Companies
64
Transactions
468
Medicare Patients
11,295
Medicare Billing
$1.0M
Payment Breakdown by Category
Education$19,979 (31.5%)
Travel$14,872 (23.4%)
Food & Beverage$14,629 (23.1%)
Consulting$8,830 (13.9%)
Other$5,150 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $19,979 | 13 | 31.5% |
| Travel and Lodging | $14,872 | 65 | 23.4% |
| Food and Beverage | $14,629 | 379 | 23.1% |
| Consulting Fee | $8,830 | 6 | 13.9% |
| Honoraria | $4,000 | 2 | 6.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,150 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $32,403 | 76 | $0 (2024) |
| Integra GPO, LLC | $7,359 | 12 | $0 (2019) |
| Janssen Biotech, Inc. | $3,221 | 22 | $0 (2022) |
| AngioDynamics, Inc. | $3,024 | 9 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $2,599 | 25 | $0 (2024) |
| Clovis Oncology, Inc. | $2,556 | 5 | $0 (2019) |
| PFIZER INC. | $2,170 | 22 | $0 (2020) |
| Boston Scientific Corporation | $983.43 | 20 | $0 (2022) |
| Astellas Pharma US Inc | $874.35 | 24 | $0 (2022) |
| Allergan, Inc. | $845.14 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $837.54 | 41 | Sumitomo Pharma America, Inc. ($176.74) |
| 2023 | $12,527 | 44 | Intuitive Surgical, Inc. ($12,003) |
| 2022 | $15,724 | 69 | Intuitive Surgical, Inc. ($11,383) |
| 2021 | $1,324 | 38 | SRS Medical Systems, Inc. ($254.68) |
| 2020 | $2,149 | 20 | Intuitive Surgical, Inc. ($1,828) |
| 2019 | $14,278 | 94 | Intuitive Surgical, Inc. ($6,108) |
| 2018 | $11,350 | 86 | Integra GPO, LLC ($3,709) |
| 2017 | $5,271 | 76 | PFIZER INC. ($1,860) |
All Payment Transactions
468 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: SURGERY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: HORMONE THERAPY | ||||||
| 11/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diagnostic Imaging | ||||||
| 10/25/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Urology Gynecology | ||||||
| 10/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Diagnostic Imaging | ||||||
| 10/04/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Diagnostic Imaging | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $16.17 | General |
| 08/09/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Urology Gynecology | ||||||
| 08/09/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/15/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: UROLOGY | ||||||
| 07/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: UROLOGY | ||||||
| 07/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,285 | 6,810 | $807,153 | $233,779 |
| 2022 | 34 | 2,608 | 3,645 | $850,789 | $234,520 |
| 2021 | 40 | 3,299 | 9,744 | $1.1M | $309,950 |
| 2020 | 35 | 3,103 | 10,622 | $916,438 | $265,878 |
Total Patients
11,295
Total Services
30,821
Medicare Billing
$1.0M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 13 | 672 | $129,024 | $45,385 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 465 | 568 | $83,224 | $36,972 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 234 | $52,524 | $21,870 | 41.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 183 | 325 | $66,800 | $21,540 | 32.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 74 | 89 | $72,837 | $17,061 | 23.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 316 | $24,520 | $15,525 | 63.3% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 19 | 22 | $81,734 | $10,792 | 13.2% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 11 | 3,040 | $19,546 | $9,686 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $24,050 | $7,919 | 32.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 66 | 84 | $12,251 | $5,307 | 43.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 32 | 46 | $68,834 | $5,258 | 7.6% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 17 | 17 | $16,796 | $5,231 | 31.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 63 | 63 | $15,610 | $4,436 | 28.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 43 | $9,934 | $4,328 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $8,122 | $3,614 | 44.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 74 | 77 | $8,084 | $3,260 | 40.3% |
| 52001 | Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | Facility | 2023 | 13 | 13 | $21,007 | $2,927 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $6,503 | $2,200 | 33.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 17 | 40 | $15,292 | $1,914 | 12.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 66 | $9,000 | $1,848 | 20.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 166 | 189 | $13,590 | $1,552 | 11.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 12 | $2,688 | $1,277 | 47.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 455 | 563 | $6,940 | $1,237 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 136 | $1,550 | $1,134 | 73.2% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 21 | 21 | $17,380 | $599.94 | 3.5% |
About Dr. James Sylora, MD
Dr. James Sylora, MD is a Urology healthcare provider based in Evergreen Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245296912.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Sylora, MD has received a total of $63,460 in payments from pharmaceutical and medical device companies, with $837.54 received in 2024. These payments were reported across 468 transactions from 64 companies. The most common payment nature is "Education" ($19,979).
As a Medicare-enrolled provider, Sylora has provided services to 11,295 Medicare beneficiaries, totaling 30,821 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Evergreen Park, IL
- Active Since 04/21/2006
- Last Updated 04/16/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1245296912
Products in Payments
- Da Vinci Surgical System (Device) $32,403
- Erleada (Drug) $3,092
- NANOKNIFE (Device) $3,013
- RUBRACA (Drug) $2,556
- Non-Covered $2,075
- SUTENT (Drug) $1,781
- AquaBeam Robotic System (Device) $775.87
- ELIGARD (Drug) $563.58
- BOTOX OAB (Drug) $500.00
- Xofigo (Drug) $476.26
- XTANDI (Drug) $403.58
- ORGOVYX (Drug) $394.56
- BOTOX (Biological) $375.00
- FIRMAGON (Drug) $348.15
- PROVENGE (Drug) $339.39
- iTIND System (Device) $299.71
- UroLift (Device) $293.35
- GENERAL BPH (Device) $263.66
- Axumin (Drug) $256.55
- UroCuff (Device) $254.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.